A popular blood pressure medicine has been recalled in a large voluntary action, with a complete list of affected products released. The recall involves more than 11,000 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, sold under the brand name Ziac, due to potential cross-contamination with a cholesterol-lowering drug.
Glenmark Pharmaceuticals Inc., based in New Jersey, announced the voluntary recall after testing reserve samples uncovered the presence of ezetimibe, a medication used to treat high cholesterol. The U.S. Food and Drug Administration (FDA) has assigned this recall a Class III risk level, meaning that exposure to the recalled product is not expected to cause adverse health effects under usual circumstances.
The affected tablet strengths range from 2.5 mg to 6.25 mg and are available in various bottle sizes. Expiration dates span from November 2025 to December 2026. The specific lot codes that identify the recalled lots are:
- 30-count bottles, NDC-68462-878-30
- 100-count bottles, NDC-68462-878-01
- 500-count bottles, NDC-68462-878-05
At this time, Glenmark and the FDA have not issued guidance on what patients should do with the recalled medication. If more information becomes available, it will be provided by the manufacturers and health authorities.
Diane Mwai, a trending news reporter for AL.com in Birmingham, Alabama, covers breaking news and the Birmingham metro area.
